Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia

British Journal of Haematology

Volumn 134, Issue 2, 2006, Pages 208-212

  Yabe, Hiromasa ^a   Inoue, Hiroyasu ^a   Matsumoto, Masae ^a   Hamanoue, Satoshi ^a   Koike, Takashi ^a   Ishiguro, Hiroyuki ^a   Koike, Hideki ^a   Suzuki, Kazuo ^a   Kato, Shunichi ^b   Kojima, Seiji ^c   Tsuchida, Masahiro ^d   Mori, Tetsuya ^e   Adachi, Souichi ^f   Tsuji, Koichiro ^g   Koike, Kenichi ^h   Morimoto, Akira ⁱ   Sako, Masahiro ^j   Yabe, Miharu ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKAI UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d Ibaragi Children's Hospital   (Japan)

^e KEIO UNIVERSITY   (Japan)

^f KYOTO UNIVERSITY   (Japan)

^g UNIVERSITY OF TOKYO   (Japan)

^h SHINSHU UNIVERSITY   (Japan)

ⁱ KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^j OSAKA CITY GENERAL HOSPITAL   (Japan)

more..

Author keywords

Alternative donors; Fanconi anaemia; Fludarabine; Haematopoietic cell transplantation; Tacrolimus

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BLADDER DISEASE; BLOOD DONOR; CAUSE OF DEATH; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; FANCONI ANEMIA; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; LIVER TOXICITY; MYELODYSPLASTIC SYNDROME; NEPHROTOXICITY; PILOT STUDY; PRIORITY JOURNAL; RADIATION DOSE; REFRACTORY ANEMIA; SEPSIS; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; THORACOABDOMINAL IRRADIATION; TREATMENT FAILURE; WHOLE BODY RADIATION;

CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FANCONI ANEMIA; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; PILOT PROJECTS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 33745122609     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06128.x     Document Type: Article

References (12)

1. Bearman S.I. Appelbaum F.R. Back A. Petersen F.B. Buckner C.D. Sullivan K.M. Schoch H.G. Fisher L.D. Thomas E.D. ( 1989) Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma. Journal of Clinical Oncology, 7, 1288 1294.
2. Boulad F. Gillio A. Small T.N. George D. Prasad V. Torok-Castanza J. Regan A.D. Collins N. Auerbach A.D. Kernan N.A. O'Reilly R.J. ( 2000) Stem cell transplantation for the treatment of Fanconi anaemia using fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts. British Journal of Haematology, 111, 1153 1157.
3. Boyer M.W. Gross T.G. Loechelt B. Leemhuis T. Filipovich A. Harris R.E. ( 2003) Low risk of graft-versus-host disease with transplantation of CD34 selected peripheral blood progenitor cells from alternative donors for Fanconi anemia. Journal of Pediatric Hematology and Oncology, 25, 890 895.
4. Gluckman E. Auerbach A.D. Horowitz M.M. Sobocinski K.A. Ash R.C. Bortin M.M. Butturini A. Camitta B.M. Champlin R.E. Friedrich W. Good R.A. Gordon-Smith E.C. Harris R.E. Klein J.P. Ortega J.J. Pasquini R. Ramsay N.K. Speck B. Vowels M.R. Zhang M.J. Gale R.P. ( 1995) Bone marrow transplantation for Fanconi anaemia. Blood, 86, 2856 2862.
5. Glucksberg H. Storb R. Fefer A. Buckner C.D. Neiman P.E. Clift R.A. Lerner K.G. Thomas E.D. ( 1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation, 18, 295 304.
6. Guardiola P.h. Pasquini R. Dokai I. Ortega J.J. van Weel-Sipman M. Marsh J.C. Ball S.E. Locatelli F. Vermylen C. Skinner R. Ljungman P. Miniero R. Shaw P.J. Souillet G. Michallet M. Bekassy A.N. Krivan G. Di Bartolomeo P. Heilmann C. Zanesco L. Cahn J.Y. Arcese W. Bacigalupo A. Gluckman E. ( 2000) Outcome of 69 allogeneic stem cell transplantation for Fanconi anaemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation. Blood, 95, 422 429.
7. Kaplan E.L. Meier P. ( 1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457 481.
8. MacMillan M.L. Auerbach A.D. Davies S.M. Defor T.E. Gillio A. Giller R. Harris R. Cairo M. Dusenbery K. Hirsch B. Ramsay N.K. Weisdorf D.J. Wagner J.E. ( 2000) Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial. British Journal of Haematology, 109, 121 129.
9. Morishima Y. Sasazuki T. Inoko H. Juji T. Akaza T. Yamamoto K. Ishikawa Y. Kato S. Sao H. Sakamaki H. Kawa K. Hamajima N. Asano S. Kodera Y. ( 2002) The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood, 99, 4200 4206.
10. Nash R.A. Pineiro L.A. Storb R. Deeg H.J. Fitzsimmons W.E. Furlong T. Hansen J.A. Gooley T. Maher R.M. Martin P. McSweeney P.A. Sullivan K.M. Anasetti C. Fay J.W. ( 1996) FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. Blood, 88, 3634 3641.
11. Niedernhofer L.J. Lalai A.S. Hoeijmakers J.H. ( 2005) Fanconi anemia (cross)linked to DNA repair. Cell, 123, 1191 1198.
12. Seidel M.G. Fritsch G. Matthes-Martin S. Lawitschka A. Lion T. Potschger U. Rosenmayr A. Fischer G. Gadner H. Peters C. ( 2005) Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation. Journal of Pediatric Hematology and Oncology, 27, 532 536.